RT Journal Article SR Electronic T1 Quantifying the impact of interventions against Plasmodium vivax malaria: a model for country-specific use JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2023.02.10.23285652 DO 10.1101/2023.02.10.23285652 A1 Champagne, C. A1 Gerhards, M. A1 Lana, J. A1 Menach, A. Le A1 Pothin, E. YR 2023 UL http://medrxiv.org/content/early/2023/02/14/2023.02.10.23285652.abstract AB In order to evaluate the impact of various intervention strategies on Plasmodium vivax dynamics, we introduce a simple mathematical model that can be easily adapted to country-specific data. The model includes case management, vector control, mass drug administration and reactive case detection interventions and is implemented in both deterministic and stochastic frameworks. It is available as an R package to enable users to calibrate and simulate it with their own data. By simulating and comparing the impact of various intervention combinations on malaria risk and burden, this model can a useful tool for strategic planning, implementation and resource mobilization.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported, in whole or in part, by the Bill & Melinda Gates Foundation [OPP1109772/INV-008108]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe computer code utilized in this manuscript is available at: https://github.com/SwissTPH/VivaxModelR. https://github.com/SwissTPH/VivaxModelR